FIB-4 Score Calculator

FIB-4 Score Calculator for Gastroenterology. In the selected AASLD metabolic pathway, scores below 1.3 generally fall below the secondary-assessment threshold; above age 65 this lower threshold becomes 2.0. Above 2.67 is a higher-risk signal. Below age 35, category reliability is limited. Historical HIV/HCV interpretation instead uses strict <1.45 and >3.25 limits.

Clinical learning case

Distinguish fibrosis triage from a fibrosis diagnosis

Fictional teaching case. Not an individual treatment recommendation.

A clinically stable 52-year-old being assessed for metabolic liver disease has AST 36 U/L, ALT 49 U/L and platelets 180 x 10^9/L. Calculate FIB-4, then identify the unanswered question after the score is available.

  1. The numerator is age x AST: 52 x 36 = 1,872. ALT belongs under the square root in the denominator, not AST.
  2. The denominator is platelets x square root of ALT: 180 x 7 = 1,260. FIB-4 = 1,872 / 1,260 = 1.486, displayed as 1.49.
  3. In the 2023 AASLD fatty-liver assessment pathway, a value at or above 1.3 prompts secondary risk assessment, commonly elastography or ELF, or referral for further stratification. It does not establish a histological fibrosis stage.

Clinical reasoning

The case has crossed a triage threshold, not a diagnostic finish line. The next question is whether there is clinically important fibrosis on further assessment. A score driven by age, aminotransferases and platelets cannot explain why any of those measurements is abnormal. Read the threshold in its intended disease and care setting rather than applying it to every abnormal liver test.

Error to avoid

Entering a platelet count of 180,000 instead of 180 while leaving the expected x 10^9/L unit unchanged makes this result 1,000 times too small. In a hand calculation that becomes about 0.00149 and appears falsely reassuring. Use the unit attached to the field, not the number copied without context from the laboratory report.

Should the same 1.3 threshold be transferred unchanged to an acutely ill 72-year-old?

No. The cited AASLD pathway uses an age-adjusted cutoff above 65 and advises against using FIB-4 during acute illness. Check applicability before categorising the score; neither age adjustment nor a low result resolves acute clinical concern.

Example documentation

FIB-4 1.49 from age 52, AST 36 U/L, ALT 49 U/L and platelets 180 x 10^9/L. Stable outpatient context. Secondary fibrosis assessment considered under the applicable liver pathway; fibrosis stage not diagnosed by FIB-4.

Sources for this lesson

Source check: 2026-09-07. Editorial content by Quick Medical Calculator. Independent clinical sign-off is not recorded for this lesson.

For shared guidance on choosing a tool and documenting results, read the clinical calculator workflow.

How this calculator works

FIB-4 = age x AST / (platelets x square root of ALT). The selectable historical HIV/HCV cutoffs are strictly below 1.45 and above 3.25. The AASLD metabolic pathway uses age-specific secondary-assessment thresholds, not the historical bands.

When to use this calculator

Use as an initial fibrosis risk assessment in a defined liver-disease pathway, not as a diagnosis. The original HIV/HCV model and a contemporary metabolic liver disease pathway do not use identical decision thresholds.

Inputs used

  • Age (completed years)
  • AST (U/L)
  • ALT (U/L)
  • Platelets (10^9/L)
  • Interpretation framework

Clinical interpretation

In the selected AASLD metabolic pathway, scores below 1.3 generally fall below the secondary-assessment threshold; above age 65 this lower threshold becomes 2.0. Above 2.67 is a higher-risk signal. Below age 35, category reliability is limited. Historical HIV/HCV interpretation instead uses strict <1.45 and >3.25 limits.

Worked example

Fictional teaching case. Age (completed years): 58; AST (U/L): 46; ALT (U/L): 30; Platelets (10^9/L): 180; Interpretation framework: Metabolic liver disease: AASLD 2023 assessment. Result: 2.706155. Above higher-risk threshold. Use an etiology- and population-appropriate sequential assessment. Acute illness and nonhepatic changes in platelets or enzymes can mislead; no score confirms or excludes fibrosis by itself.

Limitations and safety notes

FIB-4 is less accurate below age 35 and must not be used in acute illness. The older-adult threshold is 2.0 above age 65; a value at the threshold merits assessment, not reassurance. Use an etiology- and population-appropriate sequential assessment. Acute illness and nonhepatic changes in platelets or enzymes can mislead; no score confirms or excludes fibrosis by itself.

Frequently asked questions

What can change the meaning of this result?

FIB-4 is less accurate below age 35 and must not be used in acute illness. The older-adult threshold is 2.0 above age 65; a value at the threshold merits assessment, not reassurance. Use an etiology- and population-appropriate sequential assessment. Acute illness and nonhepatic changes in platelets or enzymes can mislead; no score confirms or excludes fibrosis by itself.

References

  • Original equation and strict 1.45/3.25 thresholds, abstract accessed. https://pubmed.ncbi.nlm.nih.gov/16729309/
  • AASLD 2023 Figure 2: FIB-4 age/population restrictions and sequential assessment; relevant full text accessed, not drug guidance. https://pmc.ncbi.nlm.nih.gov/articles/PMC10735173/

Editorial review and citation methodology

Maintained by the Quick Medical Calculator Editorial Team. Content record date: September 9, 2026. A content date is not evidence of independent clinical review. Individual clinical sign-off is not recorded on this page.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators